SLE / lupus nephritis
sle
Summary
KDIGO 2024 is a focused update of the lupus nephritis chapter from the 2021 Glomerular Diseases Guideline. The update incorporates the FDA/EMA approvals of belimumab and voclosporin as add-on immunosuppressive agents for LN. Recommendations follow GRADE methodology and are supplemented by expert practice points covering diagnosis, induction, maintenance, and special populations.
Current guideline: KDIGO 2024 Lupus Nephritis Guideline · 
download Anki sub-deck
Versions
- ACR / EULAR — ACR / EULAR SLE Guidelines
- Read the guideline: html
- 2024 · KDIGO — KDIGO 2024 Lupus Nephritis Guideline